|
|
|
Article 169ObjectivesArticle 169 enables the Community to participate in research programmes undertaken jointly by several Member States, including participation in the structures created for the execution of national programmes. CharacteristicsArticle 169 is potentially a very powerful instrument:
Article 169 is adopted by a co-decision process between the European Parliament and the Council. The originality of Article 169 is related to the fact that the proposal comes from the Member States. Players involvedThe political players from the Member States are the policy makers and the operational players are the programme managers of national programmes. The Commission is responsible for transforming each initiative into a formal proposal of Article 169 to the Council and Parliament who then decide through the co-decision process.Basic criteriaThe basic criteria for the selection of the proposals of Article 169 are as follows:
First achievementsSeveral topics have been identified and one topic has been submitted as a formal proposal of Article 169: “European and Developing Countries Clinical Trials Partnership” (EDCTP). This proposal was adopted by the Commission, 28 August 2002 and has been transmitted to Council and the Parliament. 1st Pilot Action - European developing countries clinical trials programme (EDCTP) |
||